metoclopramide has been researched along with Melanoma in 3 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Delayed emesis has not been seen during the antiemetic therapies." | 6.67 | [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron]. ( Baki, M; Czeglédi, F, 1994) |
| "Metoclopramide was used as an antiemetic." | 5.26 | [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)]. ( Antz, H; Doepfmer, K; FEAUX DE Lacroix, W; Groth, W; Runne, U, 1980) |
| "Delayed emesis has not been seen during the antiemetic therapies." | 2.67 | [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron]. ( Baki, M; Czeglédi, F, 1994) |
| " Regimen B, employing a lower dosage of metoclopramide and steroids and using a more simple schedule of administration should be the preferred treatment." | 2.67 | Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients. ( Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M, 1992) |
| "Metoclopramide was used as an antiemetic." | 1.26 | [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)]. ( Antz, H; Doepfmer, K; FEAUX DE Lacroix, W; Groth, W; Runne, U, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Runne, U | 1 |
| Doepfmer, K | 1 |
| Antz, H | 1 |
| Groth, W | 1 |
| FEAUX DE Lacroix, W | 1 |
| Czeglédi, F | 1 |
| Baki, M | 1 |
| Roila, F | 1 |
| Bracarda, S | 1 |
| Basurto, C | 1 |
| Sassi, M | 1 |
| Lupattelli, M | 1 |
| Picciafuoco, M | 1 |
| Boschetti, E | 1 |
| Del Favero, A | 1 |
| Tonato, M | 1 |
2 trials available for metoclopramide and Melanoma
| Article | Year |
|---|---|
[Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Huma | 1994 |
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double- | 1992 |
1 other study available for metoclopramide and Melanoma
| Article | Year |
|---|---|
[Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
Topics: Budd-Chiari Syndrome; Dacarbazine; Humans; Male; Melanoma; Metoclopramide; Middle Aged; Mycobacteriu | 1980 |